[96a5a0]: / output / allTrials / identified / NCT03588091_identified.json

Download this file

398 lines (398 with data), 16.7 kB

  1
  2
  3
  4
  5
  6
  7
  8
  9
 10
 11
 12
 13
 14
 15
 16
 17
 18
 19
 20
 21
 22
 23
 24
 25
 26
 27
 28
 29
 30
 31
 32
 33
 34
 35
 36
 37
 38
 39
 40
 41
 42
 43
 44
 45
 46
 47
 48
 49
 50
 51
 52
 53
 54
 55
 56
 57
 58
 59
 60
 61
 62
 63
 64
 65
 66
 67
 68
 69
 70
 71
 72
 73
 74
 75
 76
 77
 78
 79
 80
 81
 82
 83
 84
 85
 86
 87
 88
 89
 90
 91
 92
 93
 94
 95
 96
 97
 98
 99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
243
244
245
246
247
248
249
250
251
252
253
254
255
256
257
258
259
260
261
262
263
264
265
266
267
268
269
270
271
272
273
274
275
276
277
278
279
280
281
282
283
284
285
286
287
288
289
290
291
292
293
294
295
296
297
298
299
300
301
302
303
304
305
306
307
308
309
310
311
312
313
314
315
316
317
318
319
320
321
322
323
324
325
326
327
328
329
330
331
332
333
334
335
336
337
338
339
340
341
342
343
344
345
346
347
348
349
350
351
352
353
354
355
356
357
358
359
360
361
362
363
364
365
366
367
368
369
370
371
372
373
374
375
376
377
378
379
380
381
382
383
384
385
386
387
388
389
390
391
392
393
394
395
396
397
398
{
"info": {
"nct_id": "NCT03588091",
"official_title": "A Randomized, Muticenter Double-blind Phase III Study of Neoadjuvant Pyrotinib Plus Trastuzumab and Docetaxel Compared With Placebo Plus Trastuzumab and Docetaxel in Women With HER2 Positive Early Stage or Locally Advanced Breast Cancer",
"inclusion_criteria": "* female patients, 18 years ≤ age ≤ 75 years;\n* Performance Status- Eastern Cooperative Oncology Group (ECOG) 0-1\n* Histologically confirmed invasive breast cancer(early stage or locally advanced):Primary tumour greater than 2 cm diameter\n* HER2 positive (HER2+++ by IHC or FISH+)\n* Known hormone receptor status.\n* Cardiovascular:Baseline left ventricular ejection fraction (LVEF)≥55% measured by ECHO\n* Signed informed consent form (ICF)\nHealthy volunteers allowed\nMust be FEMALE\nMust have minimum age of 18 Years\nMust have maximum age of 75 Years",
"exclusion_criteria": "* metastatic disease (Stage IV) or inflammatory breast cancer\n* Previous or current history of malignant neoplasms, except for curatively treated:Basal and squamous cell carcinoma of the skin,Carcinoma in situ of the cervix.\n* clinically relevant cardiovascular disease:Known history of uncontrolled or symptomatic angina, clinically significant arrhythmias, congestive heart failure, transmural myocardial infarction, uncontrolled hypertension ≥180/110);\n* Unable or unwilling to swallow tablets.",
"miscellaneous_criteria": ""
},
"inclusion_lines": [
{
"line": "* female patients, 18 years ≤ age ≤ 75 years;",
"criterions": [
{
"exact_snippets": "female patients",
"criterion": "gender",
"requirements": [
{
"requirement_type": "value",
"expected_value": "female"
}
]
},
{
"exact_snippets": "18 years ≤ age ≤ 75 years",
"criterion": "age",
"requirements": [
{
"requirement_type": "range",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 18,
"unit": "years"
},
{
"operator": "<=",
"value": 75,
"unit": "years"
}
]
}
}
]
}
]
},
{
"line": "* Performance Status- Eastern Cooperative Oncology Group (ECOG) 0-1",
"criterions": [
{
"exact_snippets": "Performance Status- Eastern Cooperative Oncology Group (ECOG) 0-1",
"criterion": "Performance Status",
"requirements": [
{
"requirement_type": "scale",
"expected_value": "Eastern Cooperative Oncology Group (ECOG)"
},
{
"requirement_type": "range",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 0,
"unit": "ECOG"
},
{
"operator": "<=",
"value": 1,
"unit": "ECOG"
}
]
}
}
]
}
]
},
{
"line": "* Histologically confirmed invasive breast cancer(early stage or locally advanced):Primary tumour greater than 2 cm diameter",
"criterions": [
{
"exact_snippets": "Histologically confirmed invasive breast cancer",
"criterion": "invasive breast cancer",
"requirements": [
{
"requirement_type": "confirmation method",
"expected_value": "histologically confirmed"
}
]
},
{
"exact_snippets": "Primary tumour greater than 2 cm diameter",
"criterion": "primary tumour size",
"requirements": [
{
"requirement_type": "size",
"expected_value": {
"operator": ">",
"value": 2,
"unit": "cm"
}
}
]
}
]
},
{
"line": "* HER2 positive (HER2+++ by IHC or FISH+)",
"criterions": [
{
"exact_snippets": "HER2 positive (HER2+++ by IHC or FISH+)",
"criterion": "HER2 status",
"requirements": [
{
"requirement_type": "status",
"expected_value": "positive"
},
{
"requirement_type": "testing method",
"expected_value": [
"IHC",
"FISH"
]
}
]
}
]
},
{
"line": "* Known hormone receptor status.",
"criterions": [
{
"exact_snippets": "Known hormone receptor status.",
"criterion": "hormone receptor status",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* Cardiovascular:Baseline left ventricular ejection fraction (LVEF)≥55% measured by ECHO",
"criterions": [
{
"exact_snippets": "Baseline left ventricular ejection fraction (LVEF)≥55% measured by ECHO",
"criterion": "left ventricular ejection fraction (LVEF)",
"requirements": [
{
"requirement_type": "measurement",
"expected_value": {
"operator": ">=",
"value": 55,
"unit": "%"
}
}
]
}
]
},
{
"line": "* Signed informed consent form (ICF)",
"criterions": [
{
"exact_snippets": "Signed informed consent form (ICF)",
"criterion": "informed consent form",
"requirements": [
{
"requirement_type": "signed",
"expected_value": true
}
]
}
]
},
{
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirements": [
{
"requirement_type": "status",
"expected_value": "healthy"
}
]
}
]
},
{
"line": "Must be FEMALE",
"criterions": [
{
"exact_snippets": "Must be FEMALE",
"criterion": "gender",
"requirements": [
{
"requirement_type": "expected_value",
"expected_value": "female"
}
]
}
]
},
{
"line": "Must have minimum age of 18 Years",
"criterions": [
{
"exact_snippets": "minimum age of 18 Years",
"criterion": "age",
"requirements": [
{
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "Years"
}
}
]
}
]
},
{
"line": "Must have maximum age of 75 Years",
"criterions": [
{
"exact_snippets": "maximum age of 75 Years",
"criterion": "age",
"requirements": [
{
"requirement_type": "maximum",
"expected_value": {
"operator": "<=",
"value": 75,
"unit": "Years"
}
}
]
}
]
}
],
"exclusion_lines": [
{
"line": "* metastatic disease (Stage IV) or inflammatory breast cancer",
"criterions": [
{
"exact_snippets": "metastatic disease (Stage IV)",
"criterion": "metastatic disease",
"requirements": [
{
"requirement_type": "stage",
"expected_value": "IV"
}
]
},
{
"exact_snippets": "inflammatory breast cancer",
"criterion": "inflammatory breast cancer",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* Unable or unwilling to swallow tablets.",
"criterions": [
{
"exact_snippets": "Unable or unwilling to swallow tablets.",
"criterion": "ability to swallow tablets",
"requirements": [
{
"requirement_type": "ability",
"expected_value": true
}
]
}
]
}
],
"miscellaneous_lines": [],
"failed_inclusion": [],
"failed_exclusion": [
{
"line": "* Previous or current history of malignant neoplasms, except for curatively treated:Basal and squamous cell carcinoma of the skin,Carcinoma in situ of the cervix.",
"criterions": [
{
"exact_snippets": "Previous or current history of malignant neoplasms",
"criterion": "malignant neoplasms",
"requirements": [
{
"requirement_type": "history",
"expected_value": true
}
]
},
{
"exact_snippets": "curatively treated: Basal and squamous cell carcinoma of the skin",
"criterion": "curatively treated basal and squamous cell carcinoma of the skin",
"requirements": [
{
"requirement_type": "history",
"expected_value": false
}
]
},
{
"exact_snippets": "curatively treated: ... Carcinoma in situ of the cervix",
"criterion": "curatively treated carcinoma in situ of the cervix",
"requirements": [
{
"requirement_type": "history",
"expected_value": false
}
]
}
]
},
{
"line": "* clinically relevant cardiovascular disease:Known history of uncontrolled or symptomatic angina, clinically significant arrhythmias, congestive heart failure, transmural myocardial infarction, uncontrolled hypertension ≥180/110);",
"criterions": [
{
"exact_snippets": "clinically relevant cardiovascular disease: Known history of uncontrolled or symptomatic angina",
"criterion": "angina",
"requirements": [
{
"requirement_type": "control",
"expected_value": "uncontrolled"
},
{
"requirement_type": "symptoms",
"expected_value": "symptomatic"
}
]
},
{
"exact_snippets": "clinically relevant cardiovascular disease: ... clinically significant arrhythmias",
"criterion": "arrhythmias",
"requirements": [
{
"requirement_type": "significance",
"expected_value": "clinically significant"
}
]
},
{
"exact_snippets": "clinically relevant cardiovascular disease: ... congestive heart failure",
"criterion": "congestive heart failure",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "clinically relevant cardiovascular disease: ... transmural myocardial infarction",
"criterion": "transmural myocardial infarction",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "clinically relevant cardiovascular disease: ... uncontrolled hypertension ≥180/110",
"criterion": "hypertension",
"requirements": [
{
"requirement_type": "control",
"expected_value": "uncontrolled"
},
{
"requirement_type": "severity",
"expected_value": {
"operator": ">=",
"value": 180,
"unit": "mmHg"
}
}
]
}
]
}
],
"failed_miscellaneous": []
}